INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42m ago
HOUSE PTR1m ago
SEC 13F1m ago
ROBINHOOD CHAIN1m ago
Public company

TIVCValion Bio, Inc.

CIK 0001787740

EDGAR filingsOpen in network
Disclosed transactions11
Buys / sells1 / 0
Max Insider Score47
Connections5with evidence

TIVC · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
WG
Wolf Lisa GCOO & CFO
VBIOValion Bio, Inc.
Tax withholding
F$4.24
2 sh
Sep 18, 2026Sep 24, 2026
traded Sep 18, 2026
+6dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Zikria DeanDirector, Interim CEO · Sep 24, 2026
  • ← Insider ofevidence
    Bolton SheryleDirector · Apr 20, 2026
  • ← Insider ofevidence
    Wolf Lisa GChief Financial Officer · Dec 22, 2025
23
WG
Wolf Lisa GCOO & CFO
VBIOValion Bio, Inc.
Option exercise
M
—
4 sh
Sep 18, 2026
Sep 24, 2026
traded Sep 18, 2026
+6d
SEC FORM 4

Evidence

19
WG
Wolf Lisa GCOO & CFO
VBIOValion Bio, Inc.
Option exercise
M—
4 sh
Sep 18, 2026Sep 24, 2026
traded Sep 18, 2026
+6dSEC FORM 4

Evidence

9
ZD
Zikria DeanDirector, Interim CEO
VBIOValion Bio, Inc.
Grant or award
A—
50.0K sh
Sep 22, 2026Sep 24, 2026
traded Sep 22, 2026
+2dSEC FORM 4

Evidence

47
BS
Bolton SheryleDirector
TIVCValion Bio, Inc.
Open-market purchase
BUY$10K
10.0K sh
Apr 15, 2026Apr 20, 2026
traded Apr 15, 2026
+5dSEC FORM 4

Evidence

9
EJ
Ernst JenniferDirector, Chief Executive Officer
TIVCValion Bio, Inc.
Option exercise
M—
14.7K sh
Dec 18, 2025Dec 22, 2025
traded Dec 18, 2025
+4dSEC FORM 4

Evidence

13
EJ
Ernst JenniferDirector, Chief Executive Officer
TIVCValion Bio, Inc.
Tax withholding
F$9,840
5,262 sh
Dec 18, 2025Dec 22, 2025
traded Dec 18, 2025
+4dSEC FORM 4

Evidence

21
EJ
Ernst JenniferDirector, Chief Executive Officer
TIVCValion Bio, Inc.
Option exercise
M—
14.7K sh
Dec 18, 2025Dec 22, 2025
traded Dec 18, 2025
+4dSEC FORM 4

Evidence

9
WG
Wolf Lisa GChief Financial Officer
TIVCValion Bio, Inc.
Option exercise
M—
736 sh
Dec 18, 2025Dec 22, 2025
traded Dec 18, 2025
+4dSEC FORM 4

Evidence

21
WG
Wolf Lisa GChief Financial Officer
TIVCValion Bio, Inc.
Tax withholding
F$565
302 sh
Dec 18, 2025Dec 22, 2025
traded Dec 18, 2025
+4dSEC FORM 4

Evidence

9
WG
Wolf Lisa GChief Financial Officer
TIVCValion Bio, Inc.
Option exercise
M—
736 sh
Dec 18, 2025Dec 22, 2025
traded Dec 18, 2025
+4dSEC FORM 4

Evidence

← Insider ofevidence
Ernst Jennifer
Director, Chief Executive Officer · Dec 22, 2025
Source error

Price history for TIVC is unavailable.

An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.